Discover the new Chem-Impex: Where innovation starts with a bond.

Catalog Number:
38368
CAS Number:
551942-41-7
Zanamivir hydrate
Purity:
≥ 98% (HPLC)
Documents
$344.42 /100MG
Pack Size Availability Price
Request Bulk Quote
Product Information

Zanamivir hydrate is a potent antiviral compound primarily used in the treatment and prevention of influenza. This compound acts as a neuraminidase inhibitor, effectively blocking the enzyme that facilitates the release of viral particles from infected cells, thereby limiting the spread of the virus within the respiratory tract. Its unique structure allows for high specificity and efficacy against various strains of influenza, making it a valuable tool in both clinical and research settings. Researchers have utilized Zanamivir hydrate in studies aimed at understanding viral resistance mechanisms and developing new therapeutic strategies.

In addition to its clinical applications, Zanamivir hydrate is also of interest in pharmaceutical research for its potential in combination therapies and its role in vaccine development. Its hydrophilic nature enhances its solubility, which is advantageous for formulation into inhalable products, providing a direct route to the site of infection. This compound's established safety profile and effectiveness make it a reliable choice for healthcare professionals seeking to combat influenza outbreaks and improve patient outcomes.

CAS Number
551942-41-7
Purity
≥ 98% (HPLC)
Molecular Formula
C12H20N4O7·xH2O
Molecular Weight
332.31
MDL Number
MFCD03791324
PubChem ID
53398652
Appearance
White to almost white powder to crystal
Optical Rotation
36 - 39 ° (C=1, H2O) (calculated on anhydrous substance)
Conditions
Store at 2 - 8 °C
General Information
CAS Number
551942-41-7
Purity
≥ 98% (HPLC)
Molecular Formula
C12H20N4O7·xH2O
Molecular Weight
332.31
MDL Number
MFCD03791324
PubChem ID
53398652
Appearance
White to almost white powder to crystal
Optical Rotation
36 - 39 ° (C=1, H2O) (calculated on anhydrous substance)
Conditions
Store at 2 - 8 °C
Properties
Additional property information coming soon!
-
Safety and Regulations
Hazmat
No
Antibiotic
No
DEA-regulated
No
Warnings
-
Applications

Zanamivir hydrate is widely utilized in research focused on

  • Antiviral Treatments: This compound is primarily used in the development of antiviral medications, particularly for treating influenza. Its effectiveness in inhibiting viral replication makes it a crucial component in flu therapies.
  • Respiratory Disease Management: Zanamivir hydrate is administered via inhalation, providing targeted delivery to the respiratory tract. This method enhances its efficacy in managing respiratory infections compared to oral medications.
  • Pharmaceutical Research: Researchers utilize this compound to study its pharmacokinetics and pharmacodynamics, helping to optimize dosage forms and improve patient outcomes in antiviral therapies.
  • Formulation Development: The compound is used in the formulation of inhalation aerosols and dry powder inhalers, offering advantages in stability and patient compliance over liquid formulations.
  • Comparative Studies: Zanamivir hydrate serves as a benchmark in clinical trials for new antiviral agents, allowing researchers to evaluate the effectiveness of novel compounds against established treatments.

Citations